SARCULATOR
source

SARCULATOR

(2)
Price
Free
Category
Medical
Last update
Jul 26, 2021
Publisher
DIGITAL FOREST SRL Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
2
Avg rating,
total
⭐5.0
Loading...

Description

575 chars

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 7-year overall survival (OS) and 7-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

Screenshots

https://is5-ssl.mzstatic.com/image/thumb/Purple123/v4/61/1a/0d/611a0db1-827f-a572-4830-67368d8e41dd/pr_source.png/1242x2208bb.pnghttps://is4-ssl.mzstatic.com/image/thumb/Purple123/v4/28/16/09/281609ac-59ea-e0cf-8122-eafe7ac7969a/pr_source.png/1242x2208bb.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple113/v4/76/b4/3e/76b43e57-651e-b54f-8142-d00b89d61814/pr_source.png/1242x2208bb.pnghttps://is5-ssl.mzstatic.com/image/thumb/Purple113/v4/4d/d0/a6/4dd0a69a-ac0c-dd9e-8f41-320fc22de753/pr_source.png/1242x2208bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster